Neutrophil-Lymphocyte Ratio and Pathological Response to Neoadjuvant Chemotherapy in Patients with Muscle-Invasive Bladder Cancer

Clinical Genitourinary Cancer

Volumn 13, Issue 4, 2015, Pages e229-e233

  Seah, Jo An ^a   Leibowitz Amit, Raya ^a   Atenafu, Eshetu G ^b   Alimohamed, Nimira ^a   Knox, Jennifer J ^a   Joshua, Anthony M ^a   Sridhar, Srikala S ^a,b  

^a Department of Medical Oncology and Haematology ^*  (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Inflammation; NLR; Predictive biomarkers; TCC; Urothelial cancer

Indexed keywords

CISPLATIN; GEMCITABINE; ANTINEOPLASTIC AGENT;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURGERY; CANCER SURVIVAL; CHEMOSENSITIVITY; CLINICAL ARTICLE; CYSTECTOMY; FEMALE; HUMAN; HUMAN TISSUE; HYDRONEPHROSIS; INFLAMMATION; MALE; MUSCLE INVASIVE BLADDER CANCER; NEUTROPHIL LYMPHOCYTE RATIO; RETROSPECTIVE STUDY; SMOKING; TREATMENT RESPONSE; DRUG EFFECTS; IMMUNOLOGY; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MIDDLE AGED; MUSCLE; NEOADJUVANT THERAPY; PATHOLOGY; TREATMENT OUTCOME; TUMOR INVASION; URINARY BLADDER NEOPLASMS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, ADJUVANT; CISPLATIN; FEMALE; HUMANS; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; MUSCLES; NEOADJUVANT THERAPY; NEOPLASM INVASIVENESS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 84936986201     PISSN: 15587673     EISSN: 19380682     Source Type: Journal    
DOI: 10.1016/j.clgc.2015.02.001     Document Type: Article

References (31)

1. American Cancer Society Cancer Facts and Figures 2014 2014 American Cancer Society Rockville, MD, USA
2. J.E. Rosenberg, P.R. Carroll, and E.J. Small Update on chemotherapy for advanced bladder cancer J Urol 174 2005 14 20
3. J.P. Stein, G. Lieskovsky, and R. Cote Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients J Clin Oncol 19 2001 666 675
4. H.B. Grossman, R.B. Natale, and C.M. Tangen Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer N Engl J Med 349 2003 859 866
5. K.A. David, M.I. Milowsky, and J. Ritchey Low incidence of perioperative chemotherapy for stage III bladder cancer 1998 to 2003: a report from the National Cancer Data Base J Urol 178 2007 451 454
6. Z. Zhu, Z. Shen, and C. Xu Inflammatory pathways as promising targets to increase chemotherapy response in bladder cancer Mediators Inflamm 2012 2012 528690
7. B.B. Aggarwal, R.V. Vijayalekshmi, and B. Sung Targeting inflammatory pathways for prevention and therapy of cancer: short-term friend, long-term foe Clin Cancer Res 15 2009 425 430
8. A.J. Templeton, M.G. McNamara, and B. Seruga Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis J Natl Cancer Inst 106 2014 dju124
9. P. Bassi, G.D. Ferrante, and N. Piazza Prognostic factors of outcome after radical cystectomy for bladder cancer: a retrospective study of a homogeneous patient cohort J Urol 161 1999 1494 1497
10. Y. Lotan, A. Gupta, and S.F. Shariat Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy J Clin Oncol 23 2005 6533 6539
11. B.H. Bochner, M.W. Kattan, and K.C. Vora Postoperative nomogram predicting risk of recurrence after radical cystectomy for bladder cancer J Clin Oncol 24 2006 3967 3972
12. R. Rosenblatt, A. Sherif, and E. Rintala Pathologic downstaging is a surrogate marker for efficacy and increased survival following neoadjuvant chemotherapy and radical cystectomy for muscle-invasive urothelial bladder cancer Eur Urol 61 2012 1229 1238
13. S. North, F. El-Gehani, and C. Santos Expression of nucleoside transporters and deoxycytidine kinase proteins in muscle invasive urothelial carcinoma of the bladder: correlation with pathological response to neoadjuvant platinum/gemcitabine combination chemotherapy J Urol 191 2014 35 39
14. D. Hanahan, and R.A. Weinberg Hallmarks of cancer: the next generation Cell 144 2011 646 674
15. B.J. Laird, S. Kaasa, and D.C. McMillan Prognostic factors in patients with advanced cancer: a comparison of clinicopathological factors and the development of an inflammation-based prognostic system Clin Cancer Res 19 2013 5456 5464
16. G. Gakis, T. Todenhofer, and A. Stenzl The prognostic value of hematological and systemic inflammatory disorders in invasive bladder cancer Curr Opin Urol 21 2011 428 433
17. S. Brandau, C.A. Dumitru, and S. Lang Protumor and antitumor functions of neutrophil granulocytes Semin Immunopathol 35 2013 163 176
18. F. Donskov, K.M. Bennedsgaard, and H. Von Der Maase Intratumoural and peripheral blood lymphocyte subsets in patients with metastatic renal cell carcinoma undergoing interleukin-2 based immunotherapy: association to objective response and survival Br J Cancer 87 2002 194 201
19. H. Jin, G. Zhang, and X. Liu Blood neutrophil-lymphocyte ratio predicts survival for stages III-IV gastric cancer treated with neoadjuvant chemotherapy World J Surg Oncol 11 2013 112
20. Y. Kishi, S. Kopetz, and Y.S. Chun Blood neutrophil-to-lymphocyte ratio predicts survival in patients with colorectal liver metastases treated with systemic chemotherapy Ann Surg Oncol 16 2009 614 622
21. S.C. Kao, N. Pavlakis, and R. Harvie High blood neutrophil-to-lymphocyte ratio is an indicator of poor prognosis in malignant mesothelioma patients undergoing systemic therapy Clin Cancer Res 16 2010 5805 5813
22. W. Chua, K.A. Charles, and V.E. Baracos Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer Br J Cancer 104 2011 1288 1295
23. M. Kaynar, M.E. Yildirim, and H. Badem Bladder cancer invasion predictability based on preoperative neutrophil-lymphocyte ratio Tumour Biol 35 2014 6601 6605
24. C. Can, B. Baseskioglu, and M. Yilmaz Pretreatment parameters obtained from peripheral blood sample predicts invasiveness of bladder carcinoma Urol Int 89 2012 468 472
25. T. Gondo, J. Nakashima, and Y. Ohno Prognostic value of neutrophil-to-lymphocyte ratio and establishment of novel preoperative risk stratification model in bladder cancer patients treated with radical cystectomy Urology 79 2012 1085 1091
26. A. Potretzke, L. Hillman, and K. Wong NLR is predictive of upstaging at the time of radical cystectomy for patients with urothelial carcinoma of the bladder Urol Oncol 32 2014 631 636
27. B.R. Viers, S.A. Boorjian, and I. Frank Pretreatment neutrophil-to-lymphocyte ratio is associated with advanced pathologic tumor stage and increased cancer-specific mortality among patients with urothelial carcinoma of the bladder undergoing radical cystectomy Eur Urol 66 2014 1157 1164
28. L.S. Krane, K.A. Richards, and A.K. Kader Preoperative neutrophil/lymphocyte ratio predicts overall survival and extravesical disease in patients undergoing radical cystectomy J Endourol 27 2013 1046 1050
29. A. Demirtas, V. Sabur, and E.C. Akinsal Can neutrophil-lymphocyte ratio and lymph node density be used as prognostic factors in patients undergoing radical cystectomy? ScientificWorldJournal 2013 2013 703579
30. J. Vakkila, and M.T. Lotze Inflammation and necrosis promote tumour growth Nat Rev Immunol 4 2004 641 648
31. P. Forget, J. Vandenhende, and M. Berliere Do intraoperative analgesics influence breast cancer recurrence after mastectomy? A retrospective analysis Anesth Analg 110 2010 1630 1635